NEW YORK (Reuters Health) – Interest in off-pump coronary artery bypass grafting (CABG) grew in the mid-1990s based on the belief that it could reduce the complications seen…
NEW YORK (Reuters Health) – In patients with stable angina pectoris, the heart-rate lowering drug ivabradine reduces attack frequency and nitrate consumption – and this is true even…
NEW YORK (Reuters Health) – New research suggests that coronary artery calcium score (CACS) and single-photon emission computed tomography (SPECT) provide complimentary information in predicting a person’s short-…
NEW YORK (Reuters Health) – In patients with hypertension, physicians should assess the presence of subclinical organ damage, an indication of high absolute risk for cardiovascular disease (CVD).…
NEW YORK (Reuters Health) – Intravenous infusions of iron sucrose before planned colorectal cancer surgery does not reduce perioperative blood transfusions, according to a report in the British…
NEW YORK (Reuters Health) – A central pulse pressure (PP) of 50 mmHg or higher is predictive of future MI, coronary heart disease, and other cardiovascular events, according…
NEW YORK (Reuters Health) – A secondary analysis of a previous study provides functional data that further supports the benefits of alteplase therapy when given up to 4.5…
NEW YORK (Reuters Health) – Patients with heart failure have fewer hospitalizations and lower mortality when they’re monitored remotely, either by routine telephone calls or electronic transfer of…
NEW YORK (Reuters Health) – Fewer than one third of patients hospitalized for heart failure are treated with aldosterone antagonists, even if they meet eligibility guidelines and are…
NEW YORK (Reuters Health) – Both low and high levels of adiponectin are associated with an increased risk of death in patients with type 2 diabetes, according to…